Calling all IBD researchers! The International Bowel Ultrasound Group (IBUS) is thrilled to announce a groundbreaking collaboration with Pfizer Global Medical Grants & Partnerships (GMGP) to accelerate research in the field of intestinal ultrasound (IUS).

 

Key Program Highlights:

• Funding: Three grants of up to $100,000 each will be awarded to support 12-month research projects.
• Focus Areas:

• • IUS in monitoring disease activity, treatment response, and complications in IBD
  • Perianal IUS for assessing and managing proctitis
  • Expanding the use of IUS in special populations, including pregnant women, adolescents, and children
  • Developing innovative educational strategies to enhance IUS competency among healthcare professionals
  • Evaluating the real-world effectiveness of Etrasimod treatment using IUS

 

Eligibility & Application:

• Open to: IBUS members and researchers collaborating with IBUS member organizations/institutions. Members of IBUS Governing Board and the Scientific Committee are excluded from applying.
• Deadline: October 1, 2024
• Apply via:

• • Pfizer CyberGrants Portal:  https://cdn.pfizer.com/pfizercom/2024-08/2024%20I&I%20Global%20IBUS%20Ultrasound%20in%20IBD%20RES.pdf?VersionId=4x0.a7arD8G3Pfg9dCd3vp35L4PSgdhw
  • Refer to the full RFP here.

 

Collaboration for Impact:

This partnership underscores IBUS and Pfizer's shared commitment to improving patient care through cutting-edge research. We believe that IUS has the potential to revolutionize the diagnosis, monitoring, and management of IBD, and we're excited to support the next generation of innovators in this field.

 

Seize this opportunity to contribute to groundbreaking research and make a lasting impact on the lives of IBD patients!